FDA Adverse Event Injury Summary report: N

NAVITOR VISION

MDR report key: 20498633 · Received October 21, 2024

Report

Report Number
2135147-2024-05229
Event Type
Injury
Date Received
October 21, 2024
Date of Event
September 26, 2024
Report Date
January 17, 2025
Manufacturer
ABBOTT MEDICAL
Product Code
NPT
UDI-DI
05415067045782
PMA / PMN Number
P190023
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AN EVENT OF VALVE UNDEREXPANSION, CENTRAL REGURGITATION, PERIVALVULAR LEAK (PVL), INCOMPLETE COAPTATION, PATIENT DEVICE INTERACTION PROBLEM, HEART FAILURE, AND HOSPITALIZATION WAS REPORTED. A RETURNED DEVICE ASSESSMENT COULD NOT BE PERFORMED AS THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE DEVICE HISTORY RECORD WAS REVIEWED TO ENSURE THAT EACH MANUFACTURING AND INSPECTION OPERATION WAS PERFORMED, AND THE PRODUCT MET ALL SPECIFICATIONS. BASED ON THE AVAILABLE INFORMATION AND CINE REVIEW, THE CAUSE OF THE REPORTED VALVE UNDEREXPANSION, CENTRAL REGURGITATION, PVL, AND INCOMPLETE COAPTATION COULD NOT BE CONCLUSIVELY DETERMINED. THE REPORTED HOSPITALIZATION AND UNEXPECTED MEDICAL INTERVENTION WERE RESULTS OF CASE-SPECIFIC CIRCUMSTANCES. DURING THE PROCEDURE, A POST-BALLOON AORTIC VALVULOPLASTY (POST-BAV) WAS PERFORMED. FOLLOWING THE PROCEDURE, THE PATIENT WAS ADMITTED FOR HEART FAILURE AND TREATED WITH DIURETICS. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO LABELING DESIGN OR MANUFACTURING OF THE DEVICE.

Additional Manufacturer Narrative · 0

INVESTIGATION IS NOT YET COMPLETE. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT ON (B)(6) 2024, A 25MM NAVITOR VISION TRANSCATHETER AORTIC VALVE (SERIAL: (B)(6)) WAS CHOSEN FOR IMPLANTATION UTILIZING A SMALL FLEXNAV DELIVERY SYSTEM (LOT: 9119719). PRE-DILATATION WAS PERFORMED WITH CAMEL 20 MM (GOODMAN CO., LTD.) BALLOON. SIGNIFICANT CALCIFICATION WAS OBSERVED IN THE STJ (SINOTUBLAR JUNCTION), BUT NO CALCIFICATION THAT WOULD CREATE A RISK FOR NUE WAS SEEN IN THE ANNULUS OR SOV (SINUS OF VALSALVA). DURING FIRST DEPLOYMENT ATTEMPT, NON-UNIFORM EXPANSION OCCURRED AND THE DEPTH WAS SHALLOW SO THE NAVITOR WAS RECAPTURED. SECOND ATTEMPT WAS STILL TOO SHALLOW. ON THE THIRD ATTEMPT, 80% ACHIEVED WITHOUT NON-UNIFORM EXPANSION AT DEPTH OF 5MM NON CORONARY CUSP, 3MM LEFT CORONARY CUSP. MILD PARAVALVULAR LEAK WAS PRESENT AND SLIGHT CENTRAL REGURGITATION. FULL DEPLOYMENT WAS PERFORMED. THERE WAS NO MIGRATION. AFTER GUIDEWIRE REMOVAL, MILD PVL WAS STILL OBSERVED ALONG WITH CENTRAL REGURGITATION. ON CT, THE VALVE WAS OBSERVED TO BE POORLY EXPANDED. POST BALLOON ANNULAR VALVULOPLASTY WAS PERFORMED WITH A Z-MED 22MM BALLOON. THE CT SHOWED THAT THE VALVE AREA OF THE RCC WAS LESS THAN HALF OF THAT OF THE LCC. ALSO, IN THE VALVE AREA OF THE RCC, THERE WERE PARTS WITH CONTRAST MEDIA AND PARTS WITHOUT, SHOWING A BLACK-AND-WHITE CONTRAST WHICH IS NOT SEEN IN A REGULAR CT SCAN (IT LOOKED LIKE A POLKA-DOT PATTERN.) - INDICATING THAT COAPTATION WAS POOR. THE LEAFLET MOVEMENT WAS THOUGHT TO DUE TO POOR EXPANSION. ALTHOUGH THE LVOT (LEFT VENTRICULAR OUTFLOW TRACT) WAS ELLIPTICAL IN PRE-PROCEDURAL ANALYSIS, THE VALVE EXPANDED TO A PERFECT CIRCLE, WITH NO STENT DEVIATION OBSERVED IN THIS AREA. THE ECHO FOLLOW-UP ON (B)(6) 2024 SHOWED AORTIC REGURGITATION REMAINED MILD. PATIENT WAS HOSPITALIZED FOR MONITORING. ON (B)(6) 2024, THE REGURGITATION HAD WORSENED TO SEVERE. DUE TO HEART FAILURE, PATIENT WAS GIVEN DIURETICS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1149061 NAVITOR VISION AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT ABBOTT MEDICAL 10313927 05415067045782

Patients

Seq Age Sex Outcome Treatment
1 93 YR Female Hospitalization| R SMALL FLEXNAV DELIVERY SYSTEM